Sanofi has finalized the restructuring related to Praluent with Regeneron. "Sanofi Finalizes Praulent Restructuring With Regeneron," at 0539 GMT, misstated the name of the drug in the headline. The drug is called Praluent, not Praulent.

(END) Dow Jones Newswires

April 07, 2020 04:12 ET (08:12 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.
Regeneron Pharmaceuticals (NASDAQ:REGN)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Regeneron Pharmaceuticals Charts.
Regeneron Pharmaceuticals (NASDAQ:REGN)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Regeneron Pharmaceuticals Charts.